600867.SH
通化东宝
SSE · Healthcare · Drug Manufacturers - General · CN
CNY 7.95
−1.97%Aug 24, 2026, 09:18 UTC
Tonghua Dongbao announced its first-half 2026 results: net profit attributable to shareholders was 296 million yuan, up 37.32% year-on-year, with revenue of 1.553 billion yuan, up 11.13%.
Source:Aug 11, 2026, 07:39 UTC
Tonghua Dongbao subscribed to 1.62 million convertible bonds issued by Tebao Bio for 162 million yuan, which were fully allocated and will be listed on the Shanghai Stock Exchange on August 13, 2026.
Source: